Illumina Files 8-K on Director Changes and Compensation

Ticker: ILMN · Form: 8-K · Filed: 2024-10-03T00:00:00.000Z

Sentiment: neutral

Topics: governance, executive-compensation, board-of-directors

Related Tickers: ILMN

TL;DR

Illumina's 8-K: Board shake-up and exec pay updates filed Oct 3.

AI Summary

On October 3, 2024, Illumina, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing includes the election of new directors and updates to compensatory arrangements for certain officers, though specific names and dollar amounts related to these changes are not detailed in the provided excerpt.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: medium — Changes in board composition and executive compensation can indicate internal shifts that may affect company strategy and performance.

Key Players & Entities

FAQ

What specific changes were made to Illumina's board of directors?

The filing indicates the election of new directors, but the specific names and details of their election are not provided in this excerpt.

Were there any changes to Illumina's executive officers?

The filing mentions 'Departure of Directors or Certain Officers' and 'Appointment of Certain Officers,' suggesting potential changes, but specific details are not in the provided text.

What is the nature of the updates to compensatory arrangements?

The filing notes 'Compensatory Arrangements of Certain Officers' as an item, indicating updates to executive pay, but the specifics are not detailed here.

What is the primary purpose of this 8-K filing?

The primary purpose is to report significant corporate events, including changes in directors, officers, and executive compensation, as of October 3, 2024.

Where is Illumina, Inc. headquartered?

Illumina, Inc. is headquartered in San Diego, CA, with its principal executive offices located at 5200 Illumina Way, San Diego, CA 92122.

From the Filing

0000950157-24-001364.txt : 20241003 0000950157-24-001364.hdr.sgml : 20241003 20241003170939 ACCESSION NUMBER: 0000950157-24-001364 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20241003 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241003 DATE AS OF CHANGE: 20241003 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ILLUMINA, INC. CENTRAL INDEX KEY: 0001110803 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 330804655 STATE OF INCORPORATION: DE FISCAL YEAR END: 1229 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35406 FILM NUMBER: 241352525 BUSINESS ADDRESS: STREET 1: 5200 ILLUMINA WAY CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 8582024500 MAIL ADDRESS: STREET 1: 5200 ILLUMINA WAY CITY: SAN DIEGO STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: ILLUMINA INC DATE OF NAME CHANGE: 20000331 8-K 1 form8-k.htm CURRENT REPORT false 0001110803 CA 0001110803 2024-10-03 2024-10-03 [    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 3, 2024 Illumina, Inc. (Exact name of registrant as specified in its charter) 001-35406 (Commission File Number) Delaware (State or other jurisdiction of incorporation)   33-0804655 (I.R.S. Employer Identification No.) 5200 Illumina Way , San Diego , CA 92122 (Address of principal executive offices) (Zip code) ( 858 ) 202-4500 (Registrant’s telephone number, including area code) N/A (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Common Stock, $0.01 par value Trading Symbol(s) ILMN Name of each exchange on which registered The NASDAQ Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13a of the Exchange Act. ☐ Item 5.02.  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 3, 2024 (the “Effective Date”), Illumina, Inc. (the “Company”) announced that Charles Dadswell, the Company’s General Counsel and Secretary, will leave Illumina.  He will stay on in an advisory role to Illumina’s Chief Executive Officer and the Board of Directors through March 31, 2025.  As of the Effective Date, Scott Davies, Vice President, Legal – Chief Corporate Counsel and Assistant Secretary, will serve as Interim General Counsel and Secretary. Mr. Dadswell and the Company entered

View on Read The Filing